Evaluating the efficacy and safety of a novel treatment strategy in metastatic hormone-sensitive prostate cancer

Completed enrollment | Phase III | Prostate Cancer | ≥18 years

Overview

This study evaluated the efficacy and safety of a novel treatment strategy in patients with metastatic hormone-sensitive prostate cancer. The findings contribute to scientific evidence supporting improved disease control and prolonged survival outcomes in this patient population.

Study population (general)

Adult male patients diagnosed with metastatic hormone-sensitive prostate cancer who met the general eligibility criteria of the study.

Principal Investigator

Specialist Level I, MD Nguyễn Thị Phi Yến

Contact

CTU – Email – Phone

• Từ vựng
• Hán tự
• Dịch

Đang tìm kiếm …

Tiếng Anh

Cài đặt